ERBB2 and cancer: Cancers that lack or express very low levels of ER, PR and HER2 proteins (triple negative breast cancers or TNBC) have the poorest prognosis and, concordantly, ER- PR- HER2- cells are highly dedifferentiated (anaplastic).